
Catherine Serke Williams
Examiner (ID: 6974, Phone: (571)272-4970 , Office: P/3993 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3763, 3762, 3731, 3993 |
| Total Applications | 1016 |
| Issued Applications | 626 |
| Pending Applications | 245 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16296294
[patent_doc_number] => 20200282017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => COMPOSITIONS AND METHOD FOR REDUCING VIRULENCE OF MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 16/807792
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807792 | Compositions and method for reducing virulence of microorganisms | Mar 2, 2020 | Issued |
Array
(
[id] => 17627263
[patent_doc_number] => 20220162278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY
[patent_app_type] => utility
[patent_app_number] => 17/433009
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Feb 26, 2020 | Pending |
Array
(
[id] => 17627263
[patent_doc_number] => 20220162278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY
[patent_app_type] => utility
[patent_app_number] => 17/433009
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Feb 26, 2020 | Pending |
Array
(
[id] => 17627263
[patent_doc_number] => 20220162278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY
[patent_app_type] => utility
[patent_app_number] => 17/433009
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Feb 26, 2020 | Pending |
Array
(
[id] => 16091155
[patent_doc_number] => 20200199564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/787456
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787456 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION | Feb 10, 2020 | Abandoned |
Array
(
[id] => 16598117
[patent_doc_number] => 20210024648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => MODIFIED PSEUDOMONAS EXOTOXIN A
[patent_app_type] => utility
[patent_app_number] => 16/785911
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785911 | MODIFIED PSEUDOMONAS EXOTOXIN A | Feb 9, 2020 | Abandoned |
Array
(
[id] => 16053201
[patent_doc_number] => 20200188455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/782336
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782336 | TUBE FEED FORMULATIONS AND METHODS FOR USING SAME | Feb 4, 2020 | Abandoned |
Array
(
[id] => 17505150
[patent_doc_number] => 20220098252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => INHIBITOR OF DUX4 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/425359
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425359 | INHIBITOR OF DUX4 AND USES THEREOF | Jan 26, 2020 | Abandoned |
Array
(
[id] => 17441874
[patent_doc_number] => 20220062379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
[patent_app_type] => utility
[patent_app_number] => 17/423244
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423244 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION | Jan 16, 2020 | Pending |
Array
(
[id] => 17441874
[patent_doc_number] => 20220062379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
[patent_app_type] => utility
[patent_app_number] => 17/423244
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423244 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION | Jan 16, 2020 | Pending |
Array
(
[id] => 19975944
[patent_doc_number] => 12343400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Brain tumor-targeting peptide and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/295566
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 0
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295566 | Brain tumor-targeting peptide and application thereof | Jan 16, 2020 | Issued |
Array
(
[id] => 17378141
[patent_doc_number] => 11236138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Peptide, method and composition for melanin polymerization and hair darkening
[patent_app_type] => utility
[patent_app_number] => 16/742270
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1968
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/742270 | Peptide, method and composition for melanin polymerization and hair darkening | Jan 13, 2020 | Issued |
Array
(
[id] => 16791702
[patent_doc_number] => 20210121519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => USE OF TAIL FIBER PROTEIN IN THE PREVENTION OF ACINETOBACTER BAUMANNII INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/733590
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733590 | USE OF TAIL FIBER PROTEIN IN THE PREVENTION OF ACINETOBACTER BAUMANNII INFECTIONS | Jan 2, 2020 | Abandoned |
Array
(
[id] => 17719137
[patent_doc_number] => 20220211856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => A Polypeptide EXP and its Drug Delivery System as well as Extracellular Vesicle Extraction
[patent_app_type] => utility
[patent_app_number] => 17/053244
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053244 | Polypeptide EXP and its drug delivery system as well as extracellular vesicle extraction | Dec 17, 2019 | Issued |
Array
(
[id] => 17426938
[patent_doc_number] => 20220054646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PSMA
[patent_app_type] => utility
[patent_app_number] => 17/309630
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309630 | Bicyclic peptide ligands specific for PSMA | Dec 12, 2019 | Issued |
Array
(
[id] => 16073023
[patent_doc_number] => 20200190498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/707414
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707414 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION | Dec 8, 2019 | Abandoned |
Array
(
[id] => 15711167
[patent_doc_number] => 20200102349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER
[patent_app_type] => utility
[patent_app_number] => 16/708244
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708244 | PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER | Dec 8, 2019 | Abandoned |
Array
(
[id] => 19650126
[patent_doc_number] => 12171886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Mussel adhesive protein-based photothermal agent and photothermal-responsive adhesive nanoparticles
[patent_app_type] => utility
[patent_app_number] => 17/416685
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 6124
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416685
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416685 | Mussel adhesive protein-based photothermal agent and photothermal-responsive adhesive nanoparticles | Dec 3, 2019 | Issued |
Array
(
[id] => 17369958
[patent_doc_number] => 20220025010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Modified GIP Peptide Analogues
[patent_app_type] => utility
[patent_app_number] => 17/298444
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298444 | Modified GIP peptide analogues | Dec 2, 2019 | Issued |
Array
(
[id] => 15898427
[patent_doc_number] => 20200148732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => SMALL MOLECULES BLOCKING HISTONE READER DOMAINS
[patent_app_type] => utility
[patent_app_number] => 16/699435
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/699435 | Small molecules blocking histone reader domains | Nov 28, 2019 | Issued |